Show
Sort by
-
Yttrium-90 radioembolization versus drug-eluting beads chemoembolization for unresectable hepatocellular carcinoma : results from the TRACE phase 2 randomized controlled trial
-
Neurometabolic and gliovascular changes in murine hepatic encephalopathy
-
Development of ECM mimicking 3D-hydrogel scaffolds for liver tissue engineering
-
- Journal Article
- A1
- open access
Children with autoimmune liver disease have limited access to age : appropriate drug formulations, results from a European survey
-
Long-term obeticholic acid (OCA) for primary biliary cholangitis (PBC) in a clinical trial improved event free survival (death, liver transplant and hepatic decompensation) compared to external controls from the GLOBAL PBC real-world database
-
A multicentric study to estimate mortality and graft loss risk after liver transplantation (LT) in patients with recurrent primary biliary cholangitis (PBC)
-
Enhanced liver fibrosis score correlates with transient elastography in patients with treated autoimmune hepatitis
-
Pretransplant changes in serum protein glycosylation relate to risk of HCC recurrence after liver transplantation and provide a potential prognostic biomarker : a proof-of-concept study
-
Validation of a glycomics-based test associated with risk of HCC development in cirrhosis
-
Glycomics-based serum marker as reliable tool for assessment of viral response after treatment with direct-acting antiviral drugs in hepatitis C virus infection
-
Liver transplant for porto-sinusoidal vascular disease (psvd) : long-term outcome
-
Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure
-
Hepatobiliary malignancy surveillance strategies in primary sclerosing cholangitis associate with reduced mortality
-
- Journal Article
- A1
- open access
PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis
-
Health status of patients with autoimmune hepatitis is not affected by the SARS-CoV-2 outbreak in Flanders, Belgium